Table 2.
Banked allogeneic multi-virus-specific T cells
| Product Code | Number of Patients Treated | CD8+ T cell specificity | CD4+ T cell specificity |
|---|---|---|---|
| MVT-002 | 5 | AdV, CMV, EBV | AdV, BKV/JCV, EBV |
| MVT-003 | 5 | EBV | AdV, BKV/JCV, EBV |
| MVT-004 | 4 | EBV | AdV |
| MVT-005 | 2 | AdV, BKV/JCV, EBV | AdV, BKV/JCV, EBV |
| MVT-007 | 1 | CMV, EBV | AdV, BKV/JCV |
| MVT-010 | 3 | CMV, EBV | AdV, CMV |
| MVT-011 | 2 | EBV | AdV, BKV/JCV, EBV |
| MVT-012 | 1 | - | AdV, BKV/JCV |
| MVT-013 | 4 | BKV/JCV | BKV/JCV |
| MVT-017 | 1 | BKV/JCV | BKV/JCV |
| MVT-019 | 4 | CMV, EBV | AdV, BKV/JCV, CMV, EBV |
| MVT-021 | 1 | BKV/JCV, EBV | AdV, BKV/JCV, EBV |
| MVT-022 | 1 | BKV/JCV, EBV | AdV, BKV/JCV, EBV |
| MVT-026 | 1 | EBV | AdV, BKV/JCV, EBV |
| MVT-027 | 8 | CMV, EBV | AdV, BKV/JCV |
| MVT-028 | 4 | BKV/JCV, EBV | AdV, EBV |
| MVT-029 | 6 | CMV, EBV | AdV, CMV, EBV |
| MVT-030 | 6 | CMV, EBV | AdV, BKV/JCV, CMV, EBV |
| MVT-031 | 1 | CMV, EBV | AdV, BKV/JCV |
| MVT-033 | 0 | EBV, BKV | AdV |